Participate in Compensated Studies

The advancement of sleep medicine through our research would not be possible without participants. Click on the topics below to explore the compensated study opportunities we have available in each category.

• Night Shift Work
• Insomnia
• Pregnancy, Stress and Sleep
• Opioid Addiction and Sleep

Night Shift Work

REACT

The goal of REACT is to help night shift workers be more alert, alleviate sleep problems, and to better understand the causes of Shift Work Disorder. Participants will wear an Apple Watch, fill out daily sleep diaries, provide saliva samples in the lab over two 24-hour visits, utilize light-therapy in the sleep lab over a 4-night visit, and may utilize virtual Cognitive Behavioral Therapy sessions. REACT does not test investigatory medications. Participation in REACT is compensated and requires in-person visits. In total, participation can last 3-4 months

For more information, email us at mtreger1@hfhs.org or see if you are eligible by completing this survey.

SHIFT

The goal of SHIFT is to test the ability of an Apple Watch and mobile app to personalize sleep treatment for night shift workers to see if their symptoms of insomnia and sleepiness improve. Participants will wear an Apple Watch, fill out daily sleep diaries, provide saliva samples in the lab over two 24-hour, and utilize light-therapy at home. SHIFT does not test investigatory medications. Participation in SHIFT is compensated and requires in-person visits. In total, participation can last 4-7 weeks.

For more information, email us at mtreger1@hfhs.org or see if you are eligible by completing this survey.

SAIL

The purpose of this research study is to test the implementation of a mobile app designed to improve sleep in night shift workers. SAIL does not test investigatory medications. Participation in SAIL is compensated and completed from the comfort of your own home (no in-person visits).

For more information, email us at jrusse12@hfhs.org or see if you are preliminarily eligible and schedule and onboarding call by completing this survey.

SUSTAIN

The goal of SUSTAIN is to evaluate the effectiveness of an investigatory medication, Solriamfetol, for treating excessive sleepiness associated with Shift Work Disorder (SWD). Participants will engage in a 12-week study where they will take Solriamfetol or a placebo before each night shift and complete daily electronic diaries to track their sleep, work schedules, and symptoms. Participation in SUSTAIN is compensated, requires in-person visits, and can be done while maintaining your regular work routine.

For more information or to see if you qualify, please email txu1@hfhs.org or complete this survey.

Insomnia

COACH

The goal of COACH is to evaluate the effectiveness of digital therapy sessions for treating insomnia. Participants will engage in six weeks of online therapy sessions and fill out daily sleep diaries using a website/mobile app called Sleepio. Participation in COACH is compensated and can be done from the comfort of your own home (no in-person visits).

For more information, email us at ikapoor1@hfhs.org or see if you are eligible by completing this survey.

Pregnancy, Stress and Sleep

STRIDE-P

This study, funded by National Institute of Mental Health, evaluates the real-world effectiveness and implementation of a mindfulness program (Perinatal Understanding of Mindful Awareness for Sleep- PUMAS) tailored to the pregnancy experience to improve maternal sleep, reduce stress, and foster the mother-child bond. STRIDE-P does not test investigatory medications. Participation in STRIDE-P is compensated and can be done from the comfort of your own home (no in-person visits).

For more information, email us at hafaneh1@hfhs.org or see if you are eligible by scheduling a call with this form.

RECONNECT

The goal of this study is to evaluate the efficacy and safety of RE104, a psychedelic, for the treatment of Postpartum Depression (PPD). Participants will undergo 9-12 clinic visits over a 3-month period, with the aim of assessing the potential for rapid symptom relief and sustained remission after a single, physician-monitored, injection. Participation in RECONNECT is compensated and requires in-person visits.

For more information, email us at agutier1@hfhs.org or schedule a screening call by texting or calling (313) 403-7791.